Loading organizations...
Key people at Ajinomoto.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 14, 2025 | Enhanced Medical Nutrition | $5.0M Series A | Ajinomoto | — |
| Mar 27, 2024 | TechMagic | $16.8M Series C | — | Oriental Land Innovations, 相原直也, Shoko Chukin Bank, 宇佐美大典 |
| May 1, 2023 | Ascend Gene & Cell Therapies | $66.0M Series A | Abingworth, Michael Beecham | Ed Mathers, RiverVest, Andrew Kozlov, Jia-Yi Har, Eric Shiozaki, Deerfield Management, Digitalis Ventures |
| Apr 19, 2021 | DAIZ | $17.0M Series B | — | ENEOS Innovation Partners, Global Brain, Golden Asia Fund II, Kanematsu Corporation, Kemuri Ventures, Kichiri, Kirin Holdings, Marubeni Corporation, Mitsui Sumitomo Insurance Venture Capital, Nippon Steel Trading, Norinchukin Bank, QB Capital, Shinkin Capital |
| Oct 18, 2017 | MycoTechnology | $42.0M Series B | — | Continental Grain Company, Health for Life Capital, Middleland Capital, S2G Ventures |